Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Bee venom shows promise for treating cancer, infections, inflammation, and hair loss.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

A surface with VEGF can specifically capture endothelial cells from flowing fluids.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Biologics for severe asthma have known side effects, but some new risks need more study.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Cow blood vessel cell secretions helped heal rat burn wounds and may treat burns and hair loss.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Vitamin E can reduce the negative effects of valproic acid on hair and skin development.

Temporary hair loss can occur after brain AVM treatment but usually regrows in 8 weeks.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

Valproic acid helps hair follicle stem cells survive better in low oxygen and glucose conditions.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.